Literature DB >> 3387500

Sensitization and tolerance to apomorphine in men: yawning, growth hormone, nausea, and hyperthermia.

H Szechtman1, J M Cleghorn, G M Brown, R D Kaplan, S Franco, K Rosenthal.   

Abstract

This study investigated whether the indices of dopaminergic function, yawning and growth hormone release induced by apomorphine, as well as the drug-induced nausea and hyperthermia, show sensitization or tolerance to repeated injections. Five normal volunteers received 12 injections of apomorphine hydrochloride (0.75 mg/70 kg) every 2 weeks. Yawning, as measured by the latency of onset and the time of peak activity, showed sensitization. The growth hormone response showed no change. Feelings of nausea and hyperthermia showed tolerance to repeated injections. These findings suggest that yawning may be a suitable index of dopaminergic function in studies of schizophrenia.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3387500     DOI: 10.1016/0165-1781(88)90015-7

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  4 in total

1.  Sensitization to apomorphine in pigeons: unaffected by latent inhibition but still due to classical conditioning.

Authors:  B Wynne; J D Delius
Journal:  Psychopharmacology (Berl)       Date:  1995-06       Impact factor: 4.530

2.  Dynamics of behavioral sensitization induced by the dopamine agonist quinpirole and a proposed central energy control mechanism.

Authors:  H Szechtman; H Talangbayan; G Canaran; H Dai; D Eilam
Journal:  Psychopharmacology (Berl)       Date:  1994-06       Impact factor: 4.530

3.  Apomorphine-induced blinking and yawning in healthy volunteers.

Authors:  O Blin; G Masson; J P Azulay; J Fondarai; G Serratrice
Journal:  Br J Clin Pharmacol       Date:  1990-11       Impact factor: 4.335

4.  Induction of tolerance of dopaminergic responses in man.

Authors:  S Lal; J X Thavundayil; N M K Ng Ying Kin; X Dai; G Schwartz; A Montoya
Journal:  J Neural Transm (Vienna)       Date:  2008-05-28       Impact factor: 3.575

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.